<antigenSupportingData>
<immunity>
</immunity>
<contraindications>
<vaccineGroup>
<contraindication>
<observationCode>116</observationCode>
<observationTitle>Severe allergic reaction after previous dose of Meningococcal B</observationTitle>
<contraindicationText>Do not vaccinate if the patient has had a severe allergic reaction after a previous dose of Meningococcal B vaccine.</contraindicationText>
<beginAge/>
<endAge/>
</contraindication>
<contraindication>
<observationCode>080</observationCode>
<observationTitle>Adverse reaction to vaccine component</observationTitle>
<contraindicationText>Do not vaccinate if the patient has had an adverse reaction to a vaccine component.</contraindicationText>
<beginAge/>
<endAge/>
</contraindication>
</vaccineGroup>
</contraindications>
<series>
<seriesName>Meningococcal B risk 2-dose series</seriesName>
<targetDisease>Meningococcal B</targetDisease>
<vaccineGroup>Meningococcal B</vaccineGroup>
<seriesAdminGuidance/>
<seriesType>Risk</seriesType>
<equivalentSeriesGroups/>
<requiredGender/>
<selectSeries>
<defaultSeries>No</defaultSeries>
<productPath>Yes</productPath>
<seriesGroupName>Increased Risk</seriesGroupName>
<seriesGroup>1</seriesGroup>
<seriesPriority>A</seriesPriority>
<seriesPreference/>
<minAgeToStart/>
<maxAgeToStart/>
</selectSeries>
<indication>
<observationCode>
<text>Patient seeks protection</text>
<code>001</code>
</observationCode>
<description>Administer to persons seeking protection.</description>
<beginAge>16 years</beginAge>
<endAge>24 years</endAge>
<guidance>A MenB vaccine series may be administered to adolescents and young adults to provide short-term protection against most strains of serogroup B meningococcal disease. The preferred age for MenB vaccination is 16-18 years (recommendation Category B).</guidance>
</indication>
<indication>
<observationCode>
<text>Undergoing elective splenectomy</text>
<code>002</code>
</observationCode>
<description>Administered to persons who are undergoing elective splenectomy if they have not previously received Meningococcal B vaccine. </description>
<beginAge>10 years</beginAge>
<endAge/>
<guidance>Vaccination 14 or more days before splenectomy is suggested.</guidance>
</indication>
<indication>
<observationCode>
<text>Microbiologists routinely exposed to Neisseria meningitidis</text>
<code>050</code>
</observationCode>
<description>Administer to microbiologists routinely exposed to isolates of Neisseria meningitidis.</description>
<beginAge>10 years</beginAge>
<endAge/>
<guidance/>
</indication>
<indication>
<observationCode>
<text>Persons at risk during an outbreak</text>
<code>070</code>
</observationCode>
<description>Administer to persons identified as at increased risk because of a serogroup B meningococcal disease outbreak</description>
<beginAge>10 years</beginAge>
<endAge/>
<guidance/>
</indication>
<indication>
<observationCode>
<text>Persistent complement, properdin, or factor B deficiency</text>
<code>151</code>
</observationCode>
<description>Administer to persons who have persistent complement component deficiencies, including inherited or chronic deficiencies in C3, C5-9, properdin, factor D, factor H, or who are taking eculizumab (Soliris).</description>
<beginAge>10 years</beginAge>
<endAge/>
<guidance/>
</indication>
<indication>
<observationCode>
<text>Anatomical or functional asplenia</text>
<code>160</code>
</observationCode>
<description>Administer to persons with anatomic or functional asplenia, including sickle cell disease.</description>
<beginAge>10 years</beginAge>
<endAge/>
<guidance/>
</indication>
<seriesDose>
<doseNumber>Dose 1</doseNumber>
<age>
<absMinAge>10 years - 4 days</absMinAge>
<minAge>10 years</minAge>
<earliestRecAge>10 years</earliestRecAge>
<latestRecAge/>
<maxAge/>
</age>
<interval/>
<allowableInterval/>
<preferableVaccine>
<vaccineType>meningococcal B, OMV</vaccineType>
<cvx>163</cvx>
<beginAge>10 years</beginAge>
<endAge/>
<tradeName>Bexsero</tradeName>
<mvx>NOV</mvx>
<volume>0.5</volume>
<forecastVaccineType>N</forecastVaccineType>
</preferableVaccine>
<allowableVaccine>
<vaccineType>meningococcal B, OMV</vaccineType>
<cvx>163</cvx>
<beginAge>10 years - 4 days</beginAge>
<endAge/>
</allowableVaccine>
<inadvertentVaccine/>
<conditionalSkip/>
<recurringDose>No</recurringDose>
<seasonalRecommendation/>
</seriesDose>
<seriesDose>
<doseNumber>Dose 2</doseNumber>
<age>
<absMinAge/>
<minAge/>
<earliestRecAge/>
<latestRecAge/>
<maxAge/>
</age>
<interval>
<fromPrevious>Y</fromPrevious>
<fromTargetDose/>
<fromMostRecent/>
<fromRelevantObs/>
<absMinInt>0 days</absMinInt>
<minInt>4 weeks</minInt>
<earliestRecInt>4 weeks</earliestRecInt>
<latestRecInt/>
<intervalPriority/>
</interval>
<allowableInterval/>
<preferableVaccine>
<vaccineType>meningococcal B, OMV</vaccineType>
<cvx>163</cvx>
<beginAge>10 years</beginAge>
<endAge/>
<tradeName>Bexsero</tradeName>
<mvx>NOV</mvx>
<volume>0.5</volume>
<forecastVaccineType>Y</forecastVaccineType>
</preferableVaccine>
<allowableVaccine>
<vaccineType>meningococcal B, OMV</vaccineType>
<cvx>163</cvx>
<beginAge>10 years</beginAge>
<endAge/>
</allowableVaccine>
<inadvertentVaccine/>
<conditionalSkip/>
<recurringDose>No</recurringDose>
<seasonalRecommendation/>
</seriesDose>
</series>
<series>
<seriesName>Meningococcal B risk 3-dose series</seriesName>
<targetDisease>Meningococcal B</targetDisease>
<vaccineGroup>Meningococcal B</vaccineGroup>
<seriesAdminGuidance/>
<seriesType>Risk</seriesType>
<equivalentSeriesGroups/>
<requiredGender/>
<selectSeries>
<defaultSeries>No</defaultSeries>
<productPath>Yes</productPath>
<seriesGroupName>Increased Risk</seriesGroupName>
<seriesGroup>1</seriesGroup>
<seriesPriority>A</seriesPriority>
<seriesPreference/>
<minAgeToStart/>
<maxAgeToStart/>
</selectSeries>
<indication>
<observationCode>
<text>Patient seeks protection</text>
<code>001</code>
</observationCode>
<description>Administer to persons seeking protection.</description>
<beginAge>16 years</beginAge>
<endAge>24 years</endAge>
<guidance>A MenB vaccine series may be administered to adolescents and young adults to provide short-term protection against most strains of serogroup B meningococcal disease. The preferred age for MenB vaccination is 16-18 years (recommendation Category B).</guidance>
</indication>
<indication>
<observationCode>
<text>Undergoing elective splenectomy</text>
<code>002</code>
</observationCode>
<description>Administered to persons who are undergoing elective splenectomy if they have not previously received Meningococcal B vaccine. </description>
<beginAge>10 years</beginAge>
<endAge/>
<guidance>Vaccination 14 or more days before splenectomy is suggested.</guidance>
</indication>
<indication>
<observationCode>
<text>Microbiologists routinely exposed to Neisseria meningitidis</text>
<code>050</code>
</observationCode>
<description>Administer to microbiologists routinely exposed to isolates of Neisseria meningitidis.</description>
<beginAge>10 years</beginAge>
<endAge/>
<guidance/>
</indication>
<indication>
<observationCode>
<text>Persons at risk during an outbreak</text>
<code>070</code>
</observationCode>
<description>Administer to persons identified as at increased risk because of a serogroup B meningococcal disease outbreak</description>
<beginAge>10 years</beginAge>
<endAge/>
<guidance/>
</indication>
<indication>
<observationCode>
<text>Persistent complement, properdin, or factor B deficiency</text>
<code>151</code>
</observationCode>
<description>Administer to persons 10 years or older with persistent complement component deficiencies, including inherited or chronic deficiencies in C3, C5-9, properdin, factor D, factor H, or who are taking eculizumab (Soliris).</description>
<beginAge>10 years</beginAge>
<endAge/>
<guidance/>
</indication>
<indication>
<observationCode>
<text>Anatomical or functional asplenia</text>
<code>160</code>
</observationCode>
<description>Administer to persons with anatomic or functional asplenia, including sickle cell disease.</description>
<beginAge>10 years</beginAge>
<endAge/>
<guidance/>
</indication>
<seriesDose>
<doseNumber>Dose 1</doseNumber>
<age>
<absMinAge>10 years - 4 days</absMinAge>
<minAge>10 years</minAge>
<earliestRecAge>10 years</earliestRecAge>
<latestRecAge/>
<maxAge/>
</age>
<interval/>
<allowableInterval/>
<preferableVaccine>
<vaccineType>meningococcal B, recombinant</vaccineType>
<cvx>162</cvx>
<beginAge>10 years</beginAge>
<endAge/>
<tradeName>Trumenba</tradeName>
<mvx>PFR</mvx>
<volume>0.5</volume>
<forecastVaccineType>N</forecastVaccineType>
</preferableVaccine>
<allowableVaccine>
<vaccineType>meningococcal B, recombinant</vaccineType>
<cvx>162</cvx>
<beginAge>10 years - 4 days</beginAge>
<endAge/>
</allowableVaccine>
<inadvertentVaccine/>
<conditionalSkip/>
<recurringDose>No</recurringDose>
<seasonalRecommendation/>
</seriesDose>
<seriesDose>
<doseNumber>Dose 2</doseNumber>
<age>
<absMinAge/>
<minAge/>
<earliestRecAge/>
<latestRecAge/>
<maxAge/>
</age>
<interval>
<fromPrevious>Y</fromPrevious>
<fromTargetDose/>
<fromMostRecent/>
<fromRelevantObs/>
<absMinInt>0 days</absMinInt>
<minInt>8 weeks</minInt>
<earliestRecInt>8 weeks</earliestRecInt>
<latestRecInt/>
<intervalPriority/>
</interval>
<allowableInterval/>
<preferableVaccine>
<vaccineType>meningococcal B, recombinant</vaccineType>
<cvx>162</cvx>
<beginAge>10 years</beginAge>
<endAge/>
<tradeName>Trumenba</tradeName>
<mvx>PFR</mvx>
<volume>0.5</volume>
<forecastVaccineType>Y</forecastVaccineType>
</preferableVaccine>
<allowableVaccine>
<vaccineType>meningococcal B, recombinant</vaccineType>
<cvx>162</cvx>
<beginAge>10 years</beginAge>
<endAge/>
</allowableVaccine>
<inadvertentVaccine/>
<conditionalSkip/>
<recurringDose>No</recurringDose>
<seasonalRecommendation/>
</seriesDose>
<seriesDose>
<doseNumber>Dose 3</doseNumber>
<age>
<absMinAge/>
<minAge/>
<earliestRecAge/>
<latestRecAge/>
<maxAge/>
</age>
<interval>
<fromPrevious>Y</fromPrevious>
<fromTargetDose/>
<fromMostRecent/>
<fromRelevantObs/>
<absMinInt>0 days</absMinInt>
<minInt>4 months</minInt>
<earliestRecInt>4 months</earliestRecInt>
<latestRecInt/>
<intervalPriority/>
</interval>
<interval>
<fromPrevious>N</fromPrevious>
<fromTargetDose>1</fromTargetDose>
<fromMostRecent/>
<fromRelevantObs/>
<absMinInt>0 days</absMinInt>
<minInt>6 months</minInt>
<earliestRecInt>6 months</earliestRecInt>
<latestRecInt/>
<intervalPriority/>
</interval>
<allowableInterval/>
<preferableVaccine>
<vaccineType>meningococcal B, recombinant</vaccineType>
<cvx>162</cvx>
<beginAge>10 years</beginAge>
<endAge/>
<tradeName>Trumenba</tradeName>
<mvx>PFR</mvx>
<volume>0.5</volume>
<forecastVaccineType>Y</forecastVaccineType>
</preferableVaccine>
<allowableVaccine>
<vaccineType>meningococcal B, recombinant</vaccineType>
<cvx>162</cvx>
<beginAge>10 years</beginAge>
<endAge/>
</allowableVaccine>
<inadvertentVaccine/>
<conditionalSkip/>
<recurringDose>No</recurringDose>
<seasonalRecommendation/>
</seriesDose>
</series>
</antigenSupportingData>
